Evidence map›Paper›PMID 39810203›Full record

ArticleJournal of translational medicine2025

Metabolic and inflammatory status in prepuberty and early adulthood for individuals with a history of extrauterine growth restriction: a cohort study.

Laura Palomino-Fernández, Inmaculada Velasco, Belén Pastor-Villaescusa, Katherine Flores-Rojas, María de la Cruz Rico, Juan Roa, Ángel Gil, Mercedes Gil-Campos

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura Palomino-Fernández *Metabolism and Investigation Unit, Maimonides Institute of Biomedicine Research of Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain.
Inmaculada Velasco *Department of Cell Biology, Physiology and Immunology, University of Córdoba, Reina Sofia University Hospital, Maimonides Institute of Biomedicine Research of Córdoba (IMIBIC), Córdoba, Spain.
Belén Pastor-VillaescusaMetabolism and Investigation Unit, Maimonides Institute of Biomedicine Research of Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain. belen.pastor@imibic.org.ORCID 0000-0003-0817-6804
Katherine Flores-RojasMetabolism and Investigation Unit, Maimonides Institute of Biomedicine Research of Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain.
María de la Cruz RicoDepartment of Biochemistry and Molecular Biology II, School of Pharmacy, Institute of Nutrition and Food Technology "José Mataix", Biomedical Research Center, University of Granada, Instituto de Investigación Biosanitaria IBS, Granada, Spain.
Juan RoaDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Reina Sofia University Hospital, Maimonides Institute of Biomedicine Research of Córdoba (IMIBIC), Córdoba, Spain.
Ángel GilDepartment of Biochemistry and Molecular Biology II, School of Pharmacy, Institute of Nutrition and Food Technology "José Mataix", Biomedical Research Center, University of Granada, Instituto de Investigación Biosanitaria IBS, Granada, Spain.
Mercedes Gil-CamposMetabolism and Investigation Unit, Maimonides Institute of Biomedicine Research of Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain.

Funding

Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía PY18-1802SOCIEDADES DE PEDIATRÍA DE ANDALUCÍA ORIENTAL, OCCIDENTAL Y EXTREMADURA (SPAOYEX) Research grant 2022 edition
6 · The paper itself

Abstract

backgroundPerinatal growth and nutrition have been shown to be determinants in the programming of different tissues, such as adipose tissue, predisposing individuals to metabolic alterations later in life. Previous studies have documented an increased risk of metabolic disturbances and low-grade inflammation in prepubertal children with a history of extrauterine growth restriction (EUGR). The aim of this study was to evaluate possible alterations resulting from impaired growth during early childhood and their impact on young adult health.

methodsThis is a longitudinal, descriptive and analytical study of a cohort with a history of EUGR recruited at prepubertal age and followed up for 10 years until the end of puberty. Anthropometric measurements, blood pressure, biochemical parameters related to lipid and carbohydrate metabolism and plasma adipokines and cytokines were analyzed.

resultsCompared with prepubertal children, young adults EUGR presented increased abdominal circumference percentiles. Moreover, insulin levels and the homeostatic model assessment for insulin resistance (HOMA-IR) index were higher in young adults, with a considerable proportion of participants (22%) becoming insulin-resistant after pubertal development. In contrast, arterial hypertension was observed in 36% of prepubertal children compared with 18% of postpubertal young adults. Lipid values were within normal ranges without differences. Adiponectin and leptin remained at similar levels in adulthood, with a decrease in resistin.

conclusionIndividuals with a history of EUGR have increased metabolic risk in adulthood, which emphasizes the importance of clinical follow-up from childhood to prevent the development of further future associated diseases.

Indexed as

InflammationPubertyAdolescentAdultChildCohort StudiesFemaleHumansInsulin ResistanceLongitudinal StudiesMaleYoung AdultAdipokinesExtrauterine growth restrictionInflammationInsulin resistanceNutritionPuberty

Identifiers

PMID39810203
PMCPMC11731142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.